CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES
BEIJING, Nov. 14, 2023 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the third quarter ended September 30, 2023.
Related news for (CASI)
- MoBot alert highlights: NASDAQ: SPHL, NASDAQ: VIVK, NASDAQ: BENFW, NASDAQ: BENF, NASDAQ: CASI (09/30/25 03:00 PM)
- Today’s Top Performers: MoBot’s Market Review 09/30/25 02:00 PM
- MoBot alert highlights: NASDAQ: INVZ, NASDAQ: TNYA, NASDAQ: RUN, NASDAQ: CASI, NYSE: UP (08/15/25 03:00 PM)
- MoBot alert highlights: NASDAQ: RUN, NASDAQ: CASI, NYSE: UP, NASDAQ: IOBT, NASDAQ: GANX (08/15/25 02:00 PM)
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/04/25 10:00 AM
